OCREVUS®
OCREVUS® (Ocrelizumab) is an immunosuppressive drug used in the treatment of Relapsing and Primary Progressive Multiple Sclerosis.
OCREVUS® is manufactured by Genentech.
Administration and Dosage:
Administration of OCREVUS® is a biweekly intravenous infusion for 2 doses followed by a 6 month maintenance dose.
Common Side Effects:
The more common side effects of OCREVUS® include infusion reactions and infections.
More information:
Please read the full Prescribing Information for OCREVUS® and discuss any questions you have with your doctor.
Indication:
OCREVUS® is indicated to treat:
Multiple Sclerosis
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!
Check our Privacy Practice